Gene · 10482
NXF1: nuclear RNA export factor 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NXF1: nuclear RNA export factor 1. Genes, record 10482. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10482
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UBU9 | Nuclear RNA export factor 1 | 619 | 15 | Ensembl, GeneID, HGNC |
Source UniProt
Patents36
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 56205 | Q9UBU9 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 56208 | Q9UBU9 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3558 | Q9UBU9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3138 | Q9UBU9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3138 | Q9UBU9 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3558 | Q9UBU9 | Espacenet |
| WO 2024240908 A1 | 2024-11-28 | 34 | Q9UBU9 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 58554 | Q9UBU9 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 58559 | Q9UBU9 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 161525 | Q9UBU9 | Espacenet |
1 to 10 of 36
See all 36 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,676
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NXF1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA080728 | Oncogenic Impact of eIF4E-dependent RNA Export in Cancer | 11 | 2025 |
| R01CA098571 | Molecular Mechanisms of eIF4E Mediated Transformation | 10 | 2025 |
| ZIABC010334 | Conserved Element DNA Vaccine | 10 | 2025 |
| R01AI044115 | Influences of HLA Class I Polymorphisms on immune responses | 9 | 2025 |
| R01AI125524 | Kinase Regulation of Nuclear Speckle Function and Splicing during Influenza Virus Infection | 7 | 2025 |
| R35GM133743 | Mechanisms and Regulation of Nuclear mRNA Export | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| ZIASC010357 | Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses | 6 | 2025 |
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 5 | 2025 |
| R01AI110221 | The Cell Biology of HIV-1 Genome Trafficking | 5 | 2025 |
1 to 10 of 1,676Source NIH's project files
See all 1,676 nih grantsPapers2,989
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A multi-responsive chemosensor for selective recognition of Pb2+, Cr3+ and Fe3+ in aqueous media with cellular imaging applications. | Spectrochim Acta A Mol Biomol Spectrosc | 2027 | 42748724 | PubTator, text mining | PubMed |
| Identifying a broad-spectrum influenza inhibitor that blocks multiple functions of viral NS1 protein. | Nat Commun | 2026 | 42823417 | PubTator, text mining | PubMed |
| Association Between PM2.5 Components and Cerebral Hypoperfusion: A Mediation Role of Inflammatory Biomarkers. | Eur J Neurol | 2026 | 42593216 | PubTator, text mining | PubMed |
| Pericardial Effusion-Is It Time to TAP? | J Am Soc Echocardiogr | 2026 | 42580563 | PubTator, text mining | PubMed |
| Are arms-based methods required to test the stable unit treatment value assumption (SUTVA) among Cochrane reviews of contagious infection prevention interventions? | Glob Epidemiol | 2026 | 42294091 | PubTator, text mining | PubMed |
| A new mechanism underlying mitochondrial dysfunction in schizophrenia - attenuated mRNA transport of the complex I subunit NDUFV2 by its pseudogene NDUFV2P1. | Schizophrenia (Heidelb) | 2026 | 42259816 | PubTator, text mining | PubMed |
| Targeted single-cell RNA and perturbation sequencing with TAP-seq. | Nat Protoc | 2026 | 42191976 | PubTator, text mining | PubMed |
| Transcription start site heterogeneity controls MDA5 sensing of unspliced HIV-1 RNAs. | Proc Natl Acad Sci U S A | 2026 | 42154552 | PubTator, text mining | PubMed |
| Immunosuppressive roles of pericytes in cancer disease: insights from a systematic review and meta-analysis. | J Transl Med | 2026 | 42129871 | PubTator, text mining | PubMed |
| Multi-pathway feature-level interpretability in MHC-I antigen presentation via concept-based modeling. | Methods | 2026 | 42102982 | PubTator, text mining | PubMed |
1 to 10 of 2,989
See all 2,989 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/10482
GET https://conductscience.org/api/genes/v1/10482/patents?page=2